Reneo Pharmaceuticals And 2 Other Stocks Under $5 Executives Are Buying
Portfolio Pulse from Avi Kapoor
Insider buying activity has been observed in three penny stocks: Exicure, Amylyx Pharmaceuticals, and Reneo Pharmaceuticals. This insider activity may indicate confidence in the companies' prospects.
September 17, 2024 | 1:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Amylyx Pharmaceuticals' CFO, James M Frates, acquired 40,000 shares at $2.53 each, totaling $101,368. This insider buying may reflect confidence in the company's future.
The CFO's purchase indicates a positive outlook on the company's future, which could lead to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Reneo Pharmaceuticals' 10% owner, Braden Michael Leonard, acquired 358,923 shares at $1.35 each, totaling $484,344. This insider buying may suggest confidence in the company's future.
The purchase by a significant shareholder suggests confidence in Reneo's future, potentially leading to positive short-term price movement.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Exicure's 10% owner, DGP Co., Ltd., purchased 237,223 shares at $3.00 each, totaling $711,669. This insider buying may indicate confidence in Exicure's future prospects.
The significant purchase by a 10% owner suggests confidence in Exicure's future, potentially leading to positive short-term price movement.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80